4.9 Reasons That May Make ARM Holdings plc A Sell

Royston Wild reveals why shares in ARM Holdings plc (LON: ARM) look set to shoot lower.

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Today I am explaining why I believe ARM Holdings (LSE: ARM) (NASDAQ: ARMH.US) is showing worrying signs of slowing revenue potential.

Royalties outlook set to become gloomier

At first glance, ARM Holdings’ October interims made for chipper reading, with revenues rising 27% during July-September to £184m and  pre-tax profits increasing 36% to £93m. But drill down a little lower, and royalties of just 4.9 US cents per microchip underlined the momentum slowdown that is becoming an increasing headache for the firm.

These average royalty revenue per unit figures for quarter three showed no growth from the corresponding 2012 period. Looking ahead, the threat of slowdown in consumer uptake in the critical tablet PC and smartphone markets, coupled with the switch to lower-priced products therein and consequent effect on royalty rates, is casting huge concerns over whether ARM Holdings can arrest this downturn in performance.

As well, the growing threat from heavyweight tech rivals — Liberum Capital expects Intel to snatch market share of between 15% and 20% of the tablet and smartphone markets in coming years, for example, from currently modest levels — is also likely to hamper turnover projections looking ahead.

And although ARM Holdings signed a record 48 new processor licences during the third quarter, Liberum notes that “many of the new licenses are in areas like networking, embedded microcontrollers and the internet of things… They are not expected to compensate for potential weakness in smartphone and tablet-related revenues which we estimate to account for about 70% of ARM’s PD royalties.”

Shares in ARM Holdings collapsed almost a third in the space of a month from May’s record summit around 1,100p, illustrating the volatility which can rapidly beset stocks carrying high valuations. Prices have since recovered strongly, worsening the firm’s already-bloated multiples and leading to fresh speculation of further weakness.

Indeed, the company currently deals on a P/E rating of 47.5 and 38.9 for 2013 and 2014 correspondingly, based on current City earnings projections. This is well above an average prospective multiple of 27.4 for the entire technology hardware and equipment sector.

And although bulls can point to bubbly earnings per share growth forecasts of 38% for this year and 22% in 2014 as justification for these high readings, the firm’s price to earnings to growth (PEG) multiples show that the stock’s price is no longer decent relative to its growth potential. These currently come in at 1.2 and 1.8 for 2013 and 2014 respectively — any reading below 1 suggests acceptable value for money.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

> Royston does not own shares in ARM Holdings.

More on Investing Articles

Dividend Shares

A 12.65% yield? Here’s the dividend forecast for this FTSE income share

Jon Smith talks through the2026/27 dividend forecast for an income stock that already has a double-digit yield but could go…

Read more »

Young Asian woman holding a cup of takeaway coffee and folders containing paperwork, on her way into the office
Investing Articles

Down 23% last year, here’s a FTSE 100 share that could rebound (and then some) in 2025!

Royston Wild thinks this dirt cheap FTSE 100 share has the ingredients to bounce back after a tough few years.…

Read more »

Investing Articles

2 beaten-down shares to consider for a Stocks and Shares ISA in 2025

These high-quality businesses have suffered recent share price setbacks. This writer thinks they're now worth considering for a Stocks and…

Read more »

Fans of Warren Buffett taking his photo
Investing For Beginners

This billionaire is copying Warren Buffett. Should I do the same?

Jon Smith reviews fresh news about how an investment billionaire is imitating Warren Buffett as he goes after an interesting…

Read more »

Investing Articles

I expect these 3 FTSE 100 shares to fly when inflation really starts to fall

Harvey Jones picks out three FTSE 100 shares whose fortunes should improve once inflation is finally on the run. They're…

Read more »

Investing Articles

After a positive Q4 update, is the Vistry share price set to bounce back?

The Vistry share price has been falling sharply as a result of cost issues in its South Division. But the…

Read more »

Investing Articles

Is it game over for the Diageo share price?

The Diageo share price is showing as much spirit as an alcohol-free cocktail. Harvey Jones is wondering whether he should…

Read more »

Young Caucasian girl showing and pointing up with fingers number three against yellow background
Investing Articles

3 key reasons why AstraZeneca’s share price looks a steal to me right now

AstraZeneca’s share price has fallen a long way from its record-breaking level last year, which indicates that I may be…

Read more »